ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Pulmonary Metastasectomy Versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): A Multicentre Randomized Clinical Trial

Wednesday, December 18, 2019

Submitted by

Marco Nardini

Source

Source Name: Trials volume 20, Article number: 718 (2019)

Source URL: https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-019-3837-y

Author(s)

Tom Treasure, Vern Farewell, Fergus Macbeth, Kathryn Monson, Norman R Williams, Chris Brew-Graves, Belinda Lees, Olivia Grigg, Lesley Fallowfield & PulMiCC Trial Group

The PulMiCC is a randomized clinical trial that tried to build more evidence for performing pulmonary metastasectomy in patients affected by advanced colorectal cancer and previously treated with curative intent. Unfortunately, the trial was stopped earlier becasue of poor recruitment and high drop out rate. The resuts are now published, and the authors question the relevance of performing pulmonary metastasectomy in order to prolong survival.